AG001TN0

163042-96-4 | β-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-

Chemical structure of β-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-, CAS 163042-96-4
AG001TN0
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 163042-96-4
Catalog Number AG001TN0(AGN-PC-0Q8C62)
Chemical Name β-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-
IUPAC Name (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
InChI InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1
InChI Key IPSYPUKKXMNCNQ-PFHKOEEOSA-N
MDL Number MFCD01861178
Molecular Formula C18H18ClIN6O4
Molecular Weight 544.7308
SMILES ClC1=NC(=C2N=CN(C2=N1)[C@H]1[C@H](O)[C@H](O)[C@H](O1)C(=O)NC)NCC1=CC(=CC=C1)I
UNII Z07JR07J6C
Synonyms
2-chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-D-ribofuranosyl)adenine, 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide, 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide, 2-Cl-IB-MECA, C-IBzA-MU, CF102 compound, 2-Cl-IB-Meca, 163042-96-4, Cl-IB-MECA, Namodenoson, C-Ibza-MU, CF-102, CI-IB-MECA, (2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide, UNII-Z07JR07J6C, 2Cl-IB-MECA, 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE, CHEMBL431733, Z07JR07J6C, CF102, 2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide, (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide, 1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-beta-D-Ribofuranuronamide, AK-60479, beta-D-Ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-, beta-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-, CF 102, Namodenoson [USAN], 2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide, Namodenoson (USAN/INN), C1-IB-MECA, AC1MI03J, 2-Chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-D-ribofuranosyl)adenine, GTPL457, MLS002153535, SCHEMBL1170028, BDBM21221, 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide, DTXSID80167504, HMS2235L10, HMS3676I05, CF-102(2-Cl-IB-MECA), ZINC3995845, MFCD01861178, AKOS022181265, AM84557, CS-5932, DB12885, SB16983, NCGC00025001-02, AC-27390, AN-17022, DS-16397, HY-12365, SMR001230862, AB0047892, Chloro-IB-MECA, solid, >=98% (HPLC), B6597, ST24034136, D11128, J-009992, 2-chloro-N6-(3-iodobenzyl)adenosine-5-N-methylcarboxamide, 2-Chloro-N6-(3-iodobenzyl)-adenosine-5 inverted exclamation marka-N-methyluronamide, (2S,3S,4R,5R)-5-(2-chloro-6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide, (2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide, (2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-2-chloro-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide, (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide, 1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-?-D-ribofuranuronamide, Chloro-IB-MECA, CF102 compound, D0U0KR, C18H18ClIN6O4, 4-BROMOPYRIDINE-2-METHANOL, C18-H18-Cl-I-N6-O4, NSC695672, CID3035850, C090034, C107562, 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine, 2-chloro-N(6)--(3-iodobenzyl)adenosine-5'-N-methyluronamide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited